Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Medicines Discovery Catapult

- PMLiVE

LifeArc launches £5m motor neurone disease drug repurposing programme

Research teams will be eligible to receive up to £750,000 per project through the programme

- PMLiVE

New UK research institute launched for motor neurone disease

The research institute will bring together MND labs, clinical centres and researchers

- PMLiVE

LSTM and LifeArc announce partnership and research fund to tackle infectious diseases

The research responds to a need for new treatments and diagnostic technologies

- PMLiVE

LifeArc launches rare disease programme with £100m investment

An initial £40m will go towards the creation of up to five rare disease research centres

- PMLiVE

LifeArc partners with UK Dementia Research Institute

Dementia affects around 900,000 people in the UK and this is expected to rise to around 1.6 million by 2040

- PMLiVE

LifeArc creates £10m COVID-19 research fund

Medical research charity joins efforts against coronavirus

25 Women Leaders in UK Healthcare

Women trailblazers helping to shape the future of healthcare (Part 1)

- PMLiVE

Research charity LifeArc cashes $1.2bn royalty from Keytruda

UK medical research charity pledges to expand its work

- PMLiVE

Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers

Will also advance proteomics research

- PMLiVE

AZ and Medicines Catapult collaborate on innovative sound tech in drug discovery

Collaborates with Medicines Discovery Catapult on AMI-MS

- PMLiVE

Medicines Discovery Catapult appoints CEO

Chris Molloy will take up the lead role in November this year

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links